School of Medicine
Showing 51-100 of 177 Results
-
Susan Galel
Associate Professor of Pathology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsTransfusion-transmitted infections and donor screening for infectious diseases. National policies for blood banks. Enhancement of transfusion safety and effectiveness, with a focus on quality assurance in blood banking and transfusion therapy; transfusion medicine education; pediatric and adult transfusion therapy.
-
Stephen J. Galli, MD
Mary Hewitt Loveless, MD, Professor in the School of Medicine and Professor of Pathology and of Microbiology and Immunology
Current Research and Scholarly InterestsThe goals of Dr. Galli's laboratory are to understand the regulation of mast cell and basophil development and function, and to develop and use genetic approaches to elucidate the roles of these cells in health and disease. We study both the roles of mast cells, basophils, and IgE in normal physiology and host defense, e.g., in responses to parasites and in enhancing resistance to venoms, and also their roles in pathology, e.g., anaphylaxis, food allergy, and asthma, both in mice and humans.
-
Sharon Markham Geaghan
Associate Professor of Pathology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsPediatric Hematopathology, Pediatric Laboratory Medicine and Pathology
-
Andrew Gentles
Associate Professor (Research) of Pathology, of Medicine (BMIR) and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsComputational systems biology
-
Lawrence Tim Goodnough
Professor of Pathology and of Medicine (Hematology), Emeritus
Current Research and Scholarly InterestsImproving blood utilization
Promoting alternatives to blood transfusion
Quality improvements -
Dita Gratzinger
Professor of Pathology
Current Research and Scholarly InterestsI have research interests in the interaction of normal and neoplastic hematolymphoid cells with the bone marrow. lymph node and spleen microenvironment and the interactions of these compartments with immune perturbation and dysregulation.
-
Wei Gu
Assistant Professor of Pathology
Current Research and Scholarly InterestsWe develop breakthrough technologies in molecular testing to advance early and minimally invasive diagnostics. The current focus is a methylation profiling platform using enriched sequencing. One output is the clarification of a patient's tumor type while using less or no tissue (liquid biopsy).
-
Michael Hendrickson
Professor of Pathology at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsDiagnosis of progressive stages of uterine cancer; classification of ovarian tumors; breast cancer diagnosis and prognostic factors, soft tissue neoplasm, uterine mesenchymal neoplasm.
-
John Higgins
Professor of Pathology
Current Research and Scholarly InterestsI work as a diagnostic surgical pathologist doing translational research in renal neoplasia and medical renal disease and neoplastic and medical liver disease. Subspecialty areas of clinical interest include diagnostic immunohistochemistry, renal, hepatic and transplant pathology.
-
Jody Elizabeth Hooper
Professor of Pathology
Current Research and Scholarly InterestsI am the Director of the Research Autopsy Collaboration at Stanford (RACS) to collect organs and tissues from decedent donors for cancer and disease research. https://med.stanford.edu/racs
I have a number of research interests associated with my autopsy work, including how the time interval between death and collection (the PMI) affects the condition and research viability of the collected tissue, how valuable blood and tissue cultures behave after death, and how autopsy results affect clinical practice in an established information loop. I have projects exploring physician and family attitudes towards autopsy and the utilization of rapid autopsy tissue in characterizing cancer evolution from genetic and immunologic standpoints. -
Brooke Howitt
Irene Adler Professor
BioDr. Howitt is a gynecologic and sarcoma pathologist, with academic interests in gynecologic mesenchymal tumors and morphologic and clinical correlates of molecular alterations in gynecologic neoplasia.
-
Michael R. Howitt
Assistant Professor of Pathology and of Microbiology and Immunology
Current Research and Scholarly InterestsOur lab is broadly interested in how intestinal microbes shape our immune system to promote both health and disease. Recently we discovered that a type of intestinal epithelial cell, called tuft cells, act as sentinels stationed along the lining of the gut. Tuft cells respond to microbes, including parasites, to initiate type 2 immunity, remodel the epithelium, and alter gut physiology. Surprisingly, these changes to the intestine rely on the same chemosensory pathway found in oral taste cells. Currently, we aim to 1) elucidate the role of specific tuft cell receptors in microbial detection. 2) To understand how protozoa and bacteria within the microbiota impact host immunity. 3) Discover how tuft cells modulate surrounding cells and tissue.
-
Peter K. Jackson
Professor of Microbiology and Immunology (Baxter Labs) and of Pathology
On Partial Leave from 02/01/2025 To 01/31/2026Current Research and Scholarly InterestsCell cycle and cyclin control of DNA replication .
-
Siddhartha Jaiswal
Associate Professor of Pathology
Current Research and Scholarly InterestsWe identified a common disorder of aging called clonal hematopoiesis of indeterminate potential (CHIP). CHIP occurs due to certain somatic mutations in blood stem cells and represents a precursor state for blood cancer, but is also associated with increased risk of cardiovascular disease and death. We hope to understand more about the biology and clinical implications of CHIP using human and model system studies.
-
Kristin Jensen
Associate Professor of Pathology
Current Research and Scholarly InterestsI am a clinical translational investigator with a primary interest in breast cancer biology, and the use of investigational and clinical ancillary techniques such as gene and tissue microarray analysis and immunohistochemistry in the diagnosis and prognosis of this disease. As a practicing cytopathologist, I also have an interest in improving the fine needle aspiration biopsy diagnosis of breast lesions, again using immunohistochemistry and gene expression analysis as adjuncts to cytomorphology.
-
Neeraja Kambham
Professor of Pathology
Current Research and Scholarly InterestsDr. Kambham's research interests primarily involve medical diseases and transplantation pathology of the kidney and liver.
-
Cansu Karakas
Assistant Professor of Pathology (Clinical Pathology)
BioDr. Cansu Karakas is an Assistant Professor, with subspecialty expertise in Breast Pathology. Her academic career spans notable institutions such as MD Anderson Cancer Center and (2010–2017) and NYU (2017-2018). She is passionate about research with a focus on HER2-driven breast cancers, artificial intelligence (AI) applications in breast cancer and identifying resistance mechanisms to guide novel, personalized therapeutic strategies in breast cancer.
-
Maya M. Kasowski
Assistant Professor of Pathology, of Medicine (Pulmonary, Allergy and Critical Care Medicine) and, by courtesy, of Genetics
BioI am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
-
Christina Kong
Professor of Pathology
Current Research and Scholarly InterestsImproving the accuracy of cytologic diagnosis through the use of ancillary techniques on specimens obtained by fine needle aspiration biopsy.
Identifying potential indicators of prognosis in head and neck squamous cell carcinomas.
Evaluating the utility of immunohistochemical stains in refining the diagnosis of squamous dysplasia of the cervix, vulva, and head and neck. -
Christian Kunder
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy main interest is in understanding the biology of human neoplasms, using traditional histopathology, molecular genetic techniques, and other modalities. In particular, I am interested in soft tissue and genitourinary neoplasms, especially prostate cancer.
I am also interested in the classification and nomenclature of neoplasms and in practical research that helps us refine these, using a variety of techniques but still principally guided by histopathology.
I also work on developing next generation sequencing-based tests for genotyping tumors and in expanding the scope of this testing with the goal of identifying patients eligible for novel targeting therapies. -
Maayan Levy
Assistant Professor of Pathology
Current Research and Scholarly InterestsThe Levy Lab studies how microbiome-brain interactions influence metabolism, behavior, and disease. By investigating how microbial signals affect neural circuits, we explore mechanisms underlying obesity, diabetes, and psychiatric conditions. The lab seeks to uncover new therapeutic targets using advanced neuroscience tools like optogenetics and imaging. Our research aims to improve understanding of how microbiome imbalances contribute to disease and how restoring balance can promote health.
-
Joseph (Joe) Lipsick
Professor of Pathology and of Genetics
Current Research and Scholarly InterestsFunction and evolution of the Myb oncogene family; function and evolution of E2F transcriptional regulators and RB tumor suppressors; epigenetic regulation of chromatin and chromosomes; cancer genetics.
-
Jonathan T.C. Liu
Professor of Pathology and Professor, by courtesy, of Bioengineering
Current Research and Scholarly InterestsBiomedical optics
In vivo microscopy
Slide-free pathology
Three-dimensional microscopy
3D pathology
Optical biopsy
Image-guided surgery
Early detection
Artificial intelligence
Machine learning
Deep learning
Computational analysis
Computational pathology
Virtual staining
Molecular imaging -
Amy Lo
Adjunct Clinical Associate Professor, Pathology
BioDr. Amy Lo is a pathologist with board certification in anatomic pathology, clinical pathology and molecular genetic pathology. She completed her MD and MS at the University of Illinois at Chicago and her residency in both anatomic and clinical pathology at Northwestern University. She then joined the faculty at Northwestern University as a Clinical Instructor and Advanced Gastrointestinal/Surgical Pathology Fellow. Amy then completed a molecular genetic pathology fellowship at Stanford University.
In 2016, Amy joined Genentech as research pathology scientist supporting drug research and development with a focus in oncology and individualized drug development.
Additionally, Amy continues clinical work as an Adjunct Clinical Associate Professor in pathology at Stanford University and Lucille Packard’s Children’s Hospital. -
Jonathan Z. Long
Associate Professor of Pathology
BioDr. Jonathan Long is an Associate Professor of Pathology and an Institute Scholar of Stanford ChEM-H (Chemistry, Engineering & Medicine for Human Health). His laboratory studies the molecular mechanisms of mammalian energy homeostasis. Dr. Long is the recipient of the Alfred P. Sloan Research Fellowship in Chemistry, the Breakthrough Sciences Award from the Ono Pharma Foundation, and the NIDDK Catalyst Award. Prior to arriving to Stanford, Dr. Long completed his Ph.D. in Chemistry at Scripps Research and his postdoctoral work at Harvard Medical School.
-
Teri A Longacre
Richard L. Kempson, MD, Professor in Surgical Pathology
Current Research and Scholarly InterestsGynecological, breast and gastrointestinal pathology with major emphasis on ovarian cancer and ovarian tumors of low malignant potential. Pathology of familial and hereditary breast-ovarian-GI cancer.
-
Alarice Cheng-Yi Lowe
Associate Professor of Pathology
BioDr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of new technology to improve clinical and molecular diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.
-
Bingwei Lu
Professor of Pathology
Current Research and Scholarly InterestsWe are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimers and Parkinsons diseases. We are using both Drosophila and mammalian models to address these fundamental questions.
-
Emma Lundberg
Associate Professor of Bioengineering and of Pathology
BioDr. Emma Lundberg is an Associate Professor of Bioengineering and Pathology at Stanford University and serves at the Director of the Cell Atlas of the Human Protein Atlas initiative in Sweden, where she is also Professor at KTH Royal Institute of Technology. At the intersection of bioimaging, proteomics, and artificial intelligence, her research aims to define the spatiotemporal organization of the human proteome at both cellular and subcellular level. Dr. Lundberg aims to develop integrated models of human cells to elucidate how variations in protein localization patterns influence cellular function, ultimately enabling the simulation of cell behavior and a systems-level understanding of how biological information is spatially encoded. The Lundberg Lab is responsible for creating the Subcellular Atlas of the Human Protein Atlas database (https://www.proteinatlas.org/). Dr. Lundberg is dedicated to building virtual cell models to simulate cell behavior, and is passionate about engaging the public in her work through citizen science games and computational challenges.
Dr. Lundberg holds a Master’s degree in Bioengineering and a PhD in Biotechnology from KTH Royal Institute of Technology in Sweden. She has served as Secretary General of the Human Proteome Organization, and is actively involved in advisory roles for numerous open-access databases and cell mapping efforts such as the CZI AI Virtual Cell, Human Cell Atlas consortium, UniProt db, Reactome db, Human Proteome Project and various pharma and biotech companies. As a token of her leadership skills and advocate for open science, she was twice recognized as top 10 under 40 for future leaders in biopharma and omics. -
Ruben Y. Luo
Assistant Professor of Pathology
Current Research and Scholarly InterestsApply top-down mass spectrometry and label-free immunoassay to the study and utilization of biomarker proteoforms in clinical diagnosis.
-
Magdalena Matusiak
Instructor, Pathology
Current Research and Scholarly InterestsMy research focuses on revealing clinically relevant prognostic markers associated with myeloid cell biology.
-
Joshua Menke
Clinical Associate Professor, Pathology
BioDr. Joshua Menke completed his hematopathology fellowship at Stanford and a cytopathology fellowship at the University of California, San Francisco (UCSF). His clinical and research interests lie at the intersection of hematopathology, cytopathology, and advanced single-cell and cell-free diagnostic techniques. As the Associate Section Director of Clinical Flow Cytometry at Stanford, Dr. Menke is developing and validating new minimal residual disease assays for detecting low levels of myeloid and lymphoid neoplasms in the post-treatment setting, as well as multiple other 12-color flow assays with the latest markers for routine phenotyping.
Dr. Menke is the recipient of the Paul E. Strandjord Young Investigator Award from the Academy of Clinical Laboratory Scientists and the Laurence J. Marton Award for Excellence in Research from UCSF for his translational work on CALR mutations at the UCSF Molecular Diagnostics Laboratory. Dr. Menke is a founding member of the Cytology-Hematopathology Interinstitutional Collaboration (CHIC), which aims to study the performance of cytology samples in diagnosing lymphoma across large datasets from five academic institutions. He currently chairs this group, leading large clinical research studies. -
Sara Michie
Professor of Pathology (Research), Emerita
Current Research and Scholarly InterestsLymphocyte/endothelial cell adhesion mechanisms involved in lymphocyte migration to sites of inflammation; regulation of expression of endothelial cell adhesion molecules.
-
Paul Salomon Mischel
Fortinet Founders Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research bridges cancer genetics, signal transduction and cellular metabolism as we aim to understand the molecular mechanisms that drive cancer development, progression, and drug resistance. We have made a series of discoveries that have identified a central role for ecDNA (extrachromosomal DNA) in cancer development, progression, accelerated tumor evolution and drug resistance.
-
Maneesh Kumar Misra
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy research goal is to utilize the cutting edge of stat of art histocompatibility testing to better understand the humoral and cellular responses in clinical transplantation, and to translate this knowledge into improved treatment, and transplant outcome.
